<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lidocaine (otic): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lidocaine (otic): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Lidocaine (otic): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="138972" href="/d/html/138972.html" rel="external">see "Lidocaine (otic): Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="139026" href="/d/html/139026.html" rel="external">see "Lidocaine (otic): Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F56977539"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ear Pain MD;</li>
<li>Ear Pain MD for Kids</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F56943659"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Analgesic, Topical;</li>
<li>
                        Local Anesthetic</li></ul></div>
<div class="block doa drugH1Div" id="F56943666"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="57033632-0576-4143-a5b5-765282c20f88">Otic pain</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otic pain: Otic:</b> Instill 2 to 3 drops to affected ear no more than 3 to 4 times daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F56943668"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F56943669"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F56943667"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F56941576"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="139026" href="/d/html/139026.html" rel="external">see "Lidocaine (otic): Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a3ea0342-091f-4077-a6c7-6f77ccc09600">Ear pain</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ear pain:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Not recommended for use in patients who have perforated eardrums or tympanostomy tubes (Bolt 2008; manufacturer's labeling). In clinical trials in patients with acute otitis media, lidocaine was administered in addition to systemic pain relief (eg, acetaminophen, ibuprofen) (AAP [Lieberthal 2013]; Bolt 2008; Kara 2022; Prasad 2008).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Lidocaine 4% otic drops</i> (eg, Ear PainMD for Kids):</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥2 years and Adolescents: Otic: Instill or apply 2 to 3 drops to affected ear(s) 3 to 4 times daily as needed. If symptoms worsen or persist for ≥7 days, discontinue use and consult health care provider (manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Lidocaine 2%:</i> Limited data available: <b>Note:</b> Aqueous formulation used in studies is not commercially available in the United States; 2% lidocaine can be administered by using the parenteral formulation or a compounded aqueous solution if necessary (Prasad 2008).</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥3 years: Otic: Instill 3 drops into affected ear(s) and allow solution to dwell in ear canal for 5 minutes; may repeat every 3 hours as needed for up to 24 hours (Bolt 2008).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Lidocaine 1%:</i> Limited data available: <b>Note</b>: Formulation used in study was 1% otic drop; no details about preparation of formulation were provided (Kara 2022).</p>
<p style="text-indent:-2em;margin-left:6em;">Children &lt;5 years: Otic: Instill 4 drops into affected ear(s) up to 4 times daily as needed for up to 48 hours (Kara 2022).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F56941577"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F56941578"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F56925319"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer's labeling.</p></div>
<div class="block coi drugH1Div" id="F56943662"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">OTC labeling: When used for self-medication, do not use if hypersensitivity to lidocaine or any component of the formulation; in large quantities, particularly over raw surfaces or blistered areas; in patients with an ear injury or perforated eardrum, in patients with tubes in the ear.</p></div>
<div class="block war drugH1Div" id="F56943663"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Not for ophthalmic use.</p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): When used for self-medication (OTC), discontinue use and notify health care provider if ear pain worsens or persists for &gt;7 days or if symptoms clear up and occur again within a few days.</p></div>
<div class="block foc drugH1Div" id="F56977540"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;">Drops, Otic, as hydrochloride</p>
<p style="text-indent:-4em;margin-left:6em;">Ear Pain MD: 4% (12.5 mL) [contains aloe, benzalkonium chloride, benzyl alcohol]</p>
<p style="text-indent:-4em;margin-left:6em;">Ear Pain MD for Kids: 4% (12.5 mL) [contains aloe, benzalkonium chloride, benzyl alcohol]</p></div>
<div class="block adm drugH1Div" id="F56943670"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Otic:</b> Not for ophthalmic use. Do not use in large amounts or on raw or blistered surfaces.</p></div>
<div class="block admp drugH1Div" id="F56941579"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Otic: For external use only; do not apply to areas that are raw or blistered. Patient should lay on their side with affected ear up; dropper should be placed at entrance of ear canal; do not allow applicator tip to enter ear canal; following administration of the dose, patient should remain on their side to ensure adequate exposure of drug; in trials, patient remained on their side for 5 minutes after dose (Bolt 2008). Do not use if the eardrum is not intact or ear tubes are in place.</p></div>
<div class="block use drugH1Div" id="F56943661"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Otic pain:</b> Temporary relief of otic pain.</p></div>
<div class="block cyt drugH1Div" id="F56981741"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F56981738"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Local Anesthetics. Specifically, the risk for methemoglobinemia may be increased.<i> Risk C: Monitor therapy</i></p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319. doi:10.1067/mpd.2001.116281<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18156478">
<a name="18156478"></a>Bolt P, Barnett P, Babl FE, Sharwood LN. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial. <i>Arch Dis Child</i>. 2008;93(1):40-44. doi:10.1136/adc.2006.110429<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/18156478/pubmed" id="18156478" target="_blank">18156478</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Ear Pain MD (lidocaine [otic]) [prescribing information]. Fort Worth, TX: Eosera Inc; March 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278. doi:10.1542/peds.99.2.268<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35325846">
<a name="35325846"></a>Kara A, Büyükcam A, Sütçü M, et al. The effectiveness of topical 1% lidocaine with systemic oral analgesics for ear pain with acute otitis media. <i>Int J Pediatr Otorhinolaryngol</i>. 2022;156:111116. doi:10.1016/j.ijporl.2022.111116<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/35325846/pubmed" id="35325846" target="_blank">35325846</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23439909">
<a name="23439909"></a>Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. <i>Pediatrics</i>. 2013;131(3):e964-e999. doi:10.1542/peds.2012-3488<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/23439909/pubmed" id="23439909" target="_blank">23439909</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18544320">
<a name="18544320"></a>Prasad S, Ewigman B. Use anesthetic drops to relieve acute otitis media pain. <i>J Fam Pract</i>. 2008;57(6):370-373.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/lidocaine-otic-drug-information/abstract-text/18544320/pubmed" id="18544320" target="_blank">18544320</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 139025 Version 7.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
